SLITRK6: A Potential Drug Target for Cellular Processes (G84189)

Target Name: SLITRK6

NCBI ID: G84189

SLITRK6

SLITRK6: A Potential Drug Target for Cellular Processes

SLITRK6 (158P1D7v.1) is a protein that is expressed in various tissues throughout the body, including the brain, muscle, heart, and liver. It is a member of the serine/threonine protein kinase (SPK) family and is involved in the regulation of cellular processes that are critical for cell survival and growth.

SLITRK6 has been identified as a potential drug target due to its involvement in a variety of cellular processes that are associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It is also expressed in tissues that are often affected by these diseases, which may make it an attractive target for therapeutic intervention.

One of the key functions of SLITRK6 is its role in the regulation of cell proliferation. It is known to play a role in the G1/S transition, which is a critical step in the cell cycle that involves the preparation of the cell for cell division.SLITRK6 has been shown to regulate the G1/S transition by activating the protein p21 (CDK4), which is a key transcription factor that is involved in the regulation of cell cycle progression.

In addition to its role in cell proliferation, SLITRK6 is also involved in the regulation of cell survival. It has been shown to play a role in the regulation of cell survival by activating the protein B-cell lymphoma 1 (Bcl-2), which is a protein that is known to promote the survival of cancer cells.

SLITRK6 is also involved in the regulation of cellular signaling pathways that are critical for cell survival and growth. It has been shown to play a role in the regulation of the PI3K/AKT signaling pathway, which is involved in the regulation of cellular signaling pathways that are critical for cell survival and growth.

In addition to its involvement in cellular signaling pathways, SLITRK6 is also involved in the regulation of inflammation. It has been shown to play a role in the regulation of inflammation by activating the protein NF-kappa-B, which is involved in the regulation of inflammation.

SLITRK6 has been shown to be involved in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It is also expressed in tissues that are often affected by these diseases, which may make it an attractive target for therapeutic intervention.

In conclusion, SLITRK6 is a protein that is involved in a variety of cellular processes that are critical for cell survival and growth. Its involvement in the regulation of cell proliferation, survival, and signaling pathways makes it an attractive target for therapeutic intervention. Further research is needed to fully understand the role of SLITRK6 in these processes and to develop effective therapies for the treatment of diseases associated with its involvement.

Protein Name: SLIT And NTRK Like Family Member 6

Functions: Regulator of neurite outgrowth required for normal hearing and vision

The "SLITRK6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLITRK6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets